Filing Flows › Electromed (ELMD) › Q3 FY26 › vs Q3 FY25
Electromed (ELMD) Q3 FY26 vs Q3 FY25 (year over year)
Electromed's revenue rose $2.9M (+18%) from $15.7M in Q3 FY25 to $18.6M in Q3 FY26. Gross margin 78.8% against 78.0% (+0.9 pts).
Electromed, Q3 FY26: revenue $18.6M (+18% year over year), operating margin 20.3%, net earnings $3.0M, operating cash flow $3.5M. The chart draws each line against Q3 FY25, the increases inside each band.
Margins
| Q3 FY26 | Q3 FY25 | Change | |
|---|---|---|---|
| Gross margin | 78.8% | 78.0% | +0.9 pts |
| Operating margin | 20.3% | 13.6% | +6.6 pts |
| Net margin | 16.2% | 12.1% | +4.1 pts |
| Free cash flow margin | 17.9% | 14.2% | +3.7 pts |
Every line
| Line | Q3 FY26 | Q3 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $18.6M | $15.7M | $2.9M | +18% |
| Gross profit | $14.6M | $12.2M | $2.4M | +20% |
| Cost of revenue | $3.9M | $3.5M | $477K | +14% |
| Other income, net | $100K | $142K | −$42K | -30% |
| Operating profit | $3.8M | $2.1M | $1.6M | +76% |
| Operating expenses | $10.9M | $10.1M | $788K | +8% |
| Pre-tax earnings | $3.9M | $2.3M | $1.6M | +69% |
| Research & development | $361K | $277K | $84K | +30% |
| SG&A | $10.5M | $9.8M | $704K | +7% |
| Net earnings | $3.0M | $1.9M | $1.1M | +59% |
| Income tax | $863K | $391K | $472K | +121% |
| Depreciation & amortization | $287K | $283K | $4K | +1% |
| Share-based compensation | $846K | $757K | $89K | +12% |
| Working capital & other | $660K | $857K | −$197K | -23% |
| Operating cash flow | $3.5M | $2.1M | $1.4M | +68% |
| Free cash flow (OCF − capex) | $3.3M | $2.2M | $1.1M | +49% |
| Capital expenditures | $147K | −$153K | $300K | — |
Questions
How much did Electromed's revenue grow year over year in Q3 FY26?
Electromed's revenue rose $2.9M (+18%) from $15.7M in Q3 FY25 to $18.6M in Q3 FY26. Gross margin 78.8% against 78.0% (+0.9 pts).